Alcohol injection for left-sided aldosterone-producing adenoma
Part of Cancer, Hormones & metabolism clinical trials.
This trial tests a less invasive treatment for a left-sided aldosterone-producing adenoma, a small growth that causes high blood pressure. Instead of surgery, a doctor uses an endoscope (a thin, flexible tube) to guide a needle and inject alcohol directly into the growth to destroy it. This approach may help people who cannot or prefer not to have surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have an aldosterone-producing adenoma (a small, non-cancerous growth in your adrenal gland that makes too much of a hormone called aldosterone) on the left side.
- You are not able or not willing to have surgery to remove the adenoma.
- You do not have an allergy to alcohol.
- You are not taking blood thinners or certain other medicines that cannot be paused for the procedure.
- You do not have other serious health conditions that would make the procedure unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares different ways of doing adrenal vein sampling (a test to find which adrenal gland is causing high blood pressure). It aims to see if combining methods works better than using just one for people with primary aldosteronism.
This trial studies whether a procedure called endoscopic ultrasound–guided radiofrequency ablation can treat primary aldosteronism (a hormone condition that can raise blood pressure and potassium issues). It may help shrink an overactive adrenal growth and reduce the need for surgery for some people.
This study tests a procedure that blocks tiny arteries in the adrenal gland to treat high blood pressure and low potassium caused by aldosteronism. It may be an option if you cannot take medications or cannot have surgery.
This trial tests whether a treatment called SAAE can improve “ventricular remodeling,” meaning changes in the heart muscle, in people with primary aldosteronism (PA). It may help the heart work more efficiently by targeting the cause of high aldosterone levels.
This study compares two treatments for primary aldosteronism (a condition causing high blood pressure due to an adrenal gland issue). One treatment is a minimally invasive procedure called superselective embolization, and the other is keyhole surgery. This trial aims to see which is better and safer for patients.
This trial studies whether a specific treatment (related to spironolactone/aldosterone support) can improve how well your blood vessels work in people with primary aldosteronism. It may help reduce blood pressure risk by improving blood vessel health.
Hear when a new Primary Aldosteronism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.